Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
31.76B | 32.92B | 23.09B | 31.98B | 31.08B | Gross Profit |
31.76B | 33.95B | 23.09B | 31.98B | 31.08B | EBIT |
0.00 | 1.03B | -1.62B | 97.00M | 2.88B | EBITDA |
1.58B | 2.43B | -2.73B | 1.36B | 2.61B | Net Income Common Stockholders |
683.00M | 1.08B | -1.18B | 416.00M | 2.06B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
23.48B | 17.27B | 22.50B | 12.48B | 16.90B | Total Assets |
353.88B | 328.84B | 302.26B | 343.44B | 466.52B | Total Debt |
6.89B | 7.37B | 8.57B | 8.42B | 11.13B | Net Debt |
-16.59B | -9.91B | -13.94B | -4.06B | -5.78B | Total Liabilities |
345.26B | 319.24B | 289.86B | 323.99B | 445.96B | Stockholders Equity |
8.30B | 8.79B | 12.09B | 19.20B | 19.55B |
Cash Flow | Free Cash Flow | |||
8.27B | -3.08B | 3.85B | 3.19B | 8.91B | Operating Cash Flow |
8.45B | -2.73B | 3.95B | 3.30B | 9.05B | Investing Cash Flow |
162.00M | -350.00M | 11.13B | -6.58B | -12.70B | Financing Cash Flow |
-2.49B | -1.82B | -5.47B | -3.91B | -339.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £14.90B | 23.75 | 5.48% | 6.15% | -1.13% | -38.11% | |
80 Outperform | £9.98B | 15.05 | 56.17% | 3.77% | 34.86% | 95.18% | |
63 Neutral | $12.46B | 9.55 | 8.14% | 17103.96% | 12.70% | -4.66% | |
63 Neutral | £3.68B | 25.20 | 5.97% | 2.11% | 26.11% | -29.43% | |
62 Neutral | £5.96B | ― | -60.34% | 8.99% | -6.33% | ― | |
55 Neutral | £13.70B | 81.87 | 4.06% | 8.75% | -21.56% | -61.14% |